On the other hand, omentin seems to exert its effects by interfering with a condition that combines diseases like obesity, diabetes, coronary artery disease, heart failure, pulmonary disease, and chronic kidney disease: a state of chronic low-grade inflammation [30]. This evidence concerns the gene ITLN1 and obesity disorder.